13 results on '"Möbus V"'
Search Results
2. The REMAR (Rhein-Main-Registry)-Study: Prospective evaluation of oncotype DX® Assay in Addition to Ki-67 for adjuvant treatment decisions in early breast cancer
3. Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases
4. Treatment of patients with advanced ovarian cancer (FIGO IIb-IV) with cisplatin/paclitaxel or carboplatin/paclitaxel — An interim analysis of the ago study protocol ovar-3
5. Phase III trial comparing epirubicin/paclitaxel vs epirubicin/cyclophosphamid as first line treatment in metastatic breast cancer: Preliminary results of a German AGO trial
6. Prediction of axillary lymphatic node status in primary breast cancer — Comparison between positron emission tomography (PET) and sentinel-node biopsy
7. P92 Low morbidity and no mortality of high-dose cyclophosphamide, thiotepa and mitoxantrone plus autologous peripheral blood stem cell support for high-risk breast cancer patients
8. Cisplatin/paclitaxel vs carboplatin/paclitaxel: Optimizing of treatment in advanced ovarian cancer
9. Cisplatin/paclitaxel vs. carboplatin/paclitaxel in 798 patients with ovarian cancer FIGO IIB-IV — Randomized phase III study the AGO (Arbeitsgemeinschaft Gynaekologische Onkologie) study group (OVAR-3 trial)
10. Treosulfan vs. leuprorelin in platin- and paclitaxel-resistant ovarian cancer: final analysis of the german ago-study group trial ovar 2.1
11. Supportive therapy with epoetin-alpha in breast cancer patients (pts) receiving dose-dense sequential chemotherapy with epirubicin, paclitaxel and cyclophosphamide (ETC)
12. 367 Poster - The REMAR (Rhein-Main-Registry)-Study: Prospective evaluation of oncotype DX® Assay in Addition to Ki-67 for adjuvant treatment decisions in early breast cancer.
13. 103 Poster Spotlight - Characteristics and clinical outcome of breast cancer patients with asymptomatic brain metastases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.